SCHEMBL24959231

SCHEMBL24959231

FC(F)(F)c1nnc(COc2cccc(Br)n2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.40
LMNA P02545 2/20 0.40
PKM P14618 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ACACB O00763 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32
FFAR1 O14842 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
RXRA P19793 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
HTT P42858 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24956394 0.83 HTR7 (0.38) HTR7LMNAPKMHSD17B10GABRA1
SCHEMBL31438105 0.83 HTR7 (0.38) HTR7LMNAPKMHSD17B10GABRA1
SCHEMBL30029312 0.79 HTR7 (0.47) HTR7LMNANPC1RAB9ASMN1; SMN2
SCHEMBL30027964 0.79 HTR7 (0.43) HTR7LMNAHSD17B10NPC1RAB9A
SCHEMBL24958809 0.79 HTR7 (0.47) HTR7LMNANPC1RAB9ASMN1; SMN2
SCHEMBL24959005 0.79 HTR7 (0.43) HTR7LMNAHSD17B10NPC1RAB9A
SCHEMBL30028670 0.78 HTR7 (0.40) HTR7LMNAPKMHSD17B10GABRA1
SCHEMBL24958754 0.78 HTR7 (0.40) HTR7LMNAPKMHSD17B10GABRA1
SCHEMBL24960044 0.78 HTR7 (0.40) HTR7LMNAPKMHSD17B10NPC1
SCHEMBL30029492 0.78 HTR7 (0.40) HTR7LMNAPKMHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295729-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-26 CN disclosed
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 HTR7 280/4885LMNA 3309/4885PKM 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.